Skip to main content

Advertisement

Table 4 Comparison of basic demographic and medical data between dual and triple users

From: Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

Variables Type of therapy P value Sig. (2-tailed)
Dual (n = 31) Triple (n = 31)
Gender
 • Male 12 18 .20
 • Female 19 13
Education
 • Uneducated 17 7 .02
 • Educated 14 24
Employment
 • Employed 6 11 .24
 • Unemployed 8 9
 • Housewives 17 11
Martial status
 • Single 8 9 .50
 • Married 23 22
Area of residence
 • Rural 3 12 .02
 • Urban 28 19
Treatment experience
 • Naïve 30 24 .05
 • Experience 1 7
Diagnosis
 • Non-cirrhotic 10 21 .01
 • Cirrhotic 21 10
Mean ± SD
Age
  56.47 ± 9.32 51.65 ± 11.03 .07
Disease duration (months)
  81.71 ± 62.86 60.48 ± 50.94 .15
PCR-T0
  655845.81 ± 997681.03 645348.15 ± 638028.61 .96
PCR-T1 (50 cases)
 • Negative 32 (51.6%)
 • Positive 18 (29.0%)
  1. PCR-T0 Polymerase Chain Reaction time 0, PCR-T1 Polymerase Chain Reaction time 1
  2. P value significant at two tailed